Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 92951-93000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05057247
Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
PHASE2Active, not recruiting
26 participants
Started: Oct 14, 2021 · Completed: Jan 1, 2026
5 conditions2 sponsors1 location
NCT05940857
US National OCS Liver Perfusion (OLP) Registry
N/ARecruiting
100,000 participants
Started: Oct 14, 2021 · Completed: Oct 31, 2031
1 condition1 sponsor22 locations
NCT04455750
A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy
PHASE3Active, not recruiting
61 participants
Started: Oct 14, 2021 · Completed: Sep 30, 2027
5 conditions2 sponsors414 locations
NCT05039788
Observational Single-center Study of the Relationship Between Arterial Hypertension and Hypervolemia Defined by Self-measurement of Impedancemetry in Kidney Transplant Patients With Transplantation Less Than 6 Months Old
N/ARecruiting
150 participants
Started: Oct 14, 2021 · Completed: Dec 14, 2025
1 condition1 sponsor1 location
NCT04805164
Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones
NARecruiting
220 participants
Started: Oct 14, 2021 · Completed: Nov 14, 2027
1 condition1 sponsor15 locations
NCT04912479
Can Connected Devices Increase the Success Rate of Benzodiazepine Withdrawals in the Elderly?
NARecruiting
100 participants
Started: Oct 14, 2021 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT05174442
ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices
N/ARecruiting
685 participants
Started: Oct 14, 2021 · Completed: Oct 14, 2025
1 condition1 sponsor34 locations
NCT06750471
Dupixent Study for Alternate Administration
PHASE4Active, not recruiting
30 participants
Started: Oct 14, 2021 · Completed: Dec 31, 2025
3 conditions4 sponsors1 location
NCT06522139
Clinical Outcome After Episealer Talus Implant in Treatment of Osteochondral Lesion of the Talus
NAActive, not recruiting
20 participants
Started: Oct 14, 2021 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05074160
OCS Liver Perfusion (OLP) Post-Approval Registry
N/AActive, not recruiting
166 participants
Started: Oct 14, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor9 locations
NCT06291597
Vaping Adverse Lung and Heart Events Cohort
N/ARecruiting
250 participants
Started: Oct 14, 2021 · Completed: Jun 30, 2032
2 conditions2 sponsors1 location
NCT04820127
Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources Use
NARecruiting
668 participants
Started: Oct 14, 2021 · Completed: Oct 14, 2024
1 condition1 sponsor16 locations
NCT05083169
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
PHASE3Active, not recruiting
587 participants
Started: Oct 14, 2021 · Completed: Dec 8, 2028
1 condition1 sponsor174 locations
NCT06484803
Resilience Among Trauma Survivors
N/AEnrolling by invitation
150 participants
Started: Oct 14, 2021 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT04656210
Myotonic Dystrophy - Vascular and Cognition
N/AActive, not recruiting
85 participants
Started: Oct 14, 2021 · Completed: Jan 31, 2029
3 conditions1 sponsor1 location
NCT05343598
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
NARecruiting
68 participants
Started: Oct 13, 2021 · Completed: Oct 31, 2026
2 conditions3 sponsors1 location
NCT05219487
Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration
N/ARecruiting
30 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04966624
Ventilatory Strategy Based on Ultrasound Lung Morphology in Patients With Focal ARDS
NARecruiting
84 participants
Started: Oct 13, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05137262
A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
PHASE2Recruiting
60 participants
Started: Oct 13, 2021 · Completed: Aug 31, 2026
2 conditions2 sponsors2 locations
NCT05030506
A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)
PHASE1Active, not recruiting
45 participants
Started: Oct 13, 2021 · Completed: Oct 21, 2026
1 condition1 sponsor5 locations
NCT04867915
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
N/ARecruiting
12,500 participants
Started: Oct 13, 2021 · Completed: Oct 31, 2026
3 conditions1 sponsor24 locations
NCT05078905
Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
N/ARecruiting
1,200 participants
Started: Oct 13, 2021 · Completed: Jan 1, 2050
3 conditions1 sponsor1 location
NCT05000866
Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples
NARecruiting
480 participants
Started: Oct 13, 2021 · Completed: May 31, 2026
2 conditions3 sponsors2 locations
NCT04274426
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
PHASE2Active, not recruiting
136 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor19 locations
NCT04948333
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
PHASE3Active, not recruiting
199 participants
Started: Oct 13, 2021 · Completed: Feb 3, 2026
1 condition1 sponsor48 locations
NCT05104983
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
PHASE2Recruiting
64 participants
Started: Oct 13, 2021 · Completed: Jun 30, 2027
2 conditions1 sponsor11 locations
NCT04923035
Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation
N/AActive, not recruiting
1,010 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2024
2 conditions6 sponsors3 locations
NCT05375591
AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer
N/ARecruiting
1,000 participants
Started: Oct 13, 2021 · Completed: Nov 1, 2026
4 conditions8 sponsors2 locations
NCT05131594
Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
N/AEnrolling by invitation
100 participants
Started: Oct 13, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05017051
Study for the Quantification in Ecological Conditions of Sensorimotor and Dysexecutive Disorders in Cerebral Palsy Patients
N/ARecruiting
442 participants
Started: Oct 13, 2021 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT05101356
A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
PHASE1/PHASE2Recruiting
77 participants
Started: Oct 13, 2021 · Completed: Jan 1, 2030
6 conditions3 sponsors1 location
NCT05025800
ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
47 participants
Started: Oct 13, 2021 · Completed: Mar 10, 2026
20 conditions1 sponsor1 location
NCT05731466
Exercise Right Ventricular Coupling in HFpEF
NARecruiting
30 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04757155
Phase II RCT of an Internet-adaptation of Managing Cancer and Living Meaningfully (iCALM)
NAActive, not recruiting
50 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05029882
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
PHASE1Active, not recruiting
520 participants
Started: Oct 13, 2021 · Completed: Nov 30, 2027
4 conditions1 sponsor82 locations
NCT05109312
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.
PHASE4Active, not recruiting
90 participants
Started: Oct 12, 2021 · Completed: Jun 30, 2024
1 condition1 sponsor7 locations
NCT05196100
Acceptability of an Interim Socket System
NAActive, not recruiting
15 participants
Started: Oct 12, 2021 · Completed: Nov 28, 2024
1 condition4 sponsors2 locations
NCT04846309
Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy
PHASE1Recruiting
16 participants
Started: Oct 12, 2021 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT04234360
Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation
PHASE3Recruiting
600 participants
Started: Oct 12, 2021 · Completed: Jan 12, 2025
1 condition1 sponsor22 locations
NCT05050240
BATokines as Biomarkers of Brown Fat in Humans
NAActive, not recruiting
20 participants
Started: Oct 12, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05124964
Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors
N/ARecruiting
150 participants
Started: Oct 12, 2021 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT05761314
Solid Tumors in RASopathies
NARecruiting
100 participants
Started: Oct 12, 2021 · Completed: Oct 12, 2026
4 conditions1 sponsor1 location
NCT05036109
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
NAActive, not recruiting
16 participants
Started: Oct 12, 2021 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT04868305
Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures
NARecruiting
170 participants
Started: Oct 12, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05038553
Chronic Pain in Rheumatoid Arthritis
N/ARecruiting
125 participants
Started: Oct 12, 2021 · Completed: Apr 30, 2026
2 conditions6 sponsors5 locations
NCT04450953
The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.
PHASE3Recruiting
36 participants
Started: Oct 12, 2021 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT05995951
Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder
NARecruiting
10 participants
Started: Oct 12, 2021 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT05064085
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer
PHASE1Active, not recruiting
13 participants
Started: Oct 12, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05034835
Impact of Compression Garments on Pain in Patients With Complex Regional Pain Syndrome of the Upper Limbs.
NARecruiting
60 participants
Started: Oct 12, 2021 · Completed: Oct 31, 2026
1 condition4 sponsors1 location
NCT05321017
Wrist Extensor MEP Up-conditioning for Individuals With Incomplete Spinal Cord Injury
NARecruiting
5 participants
Started: Oct 12, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location